Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-08
2007-05-08
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S405000, C548S362100, C548S361100, C548S362500
Reexamination Certificate
active
10724971
ABSTRACT:
This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II:wherein R3is optionally substituted aryl or heteroaryl, R1and R2are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts thereof. The invention further relates to processes for preparing such compounds, to pharmaceutical compositions containing such compounds, and to methods for their use as therapeutic agents.
REFERENCES:
patent: 5668145 (1997-09-01), Bright
patent: 5705646 (1998-01-01), Bright et al.
patent: 5712303 (1998-01-01), Faraci et al.
patent: 5760225 (1998-06-01), Yuan
patent: 6005109 (1999-12-01), Faraci et al.
patent: 6200979 (2001-03-01), Bright et al.
patent: 6897231 (2005-05-01), Bhagwat et al.
patent: 6914062 (2005-07-01), Hayama et al.
patent: 2004/0167127 (2004-08-01), Steffan et al.
patent: WO99/23077 (1999-05-01), None
patent: WO 00/27394 (2000-05-01), None
patent: WO 01/58869 (2001-08-01), None
patent: WO-2002/002550 (2002-01-01), None
patent: WO 02/16348 (2002-02-01), None
patent: WO 03/035625 (2003-05-01), None
patent: WO 03/078403 (2003-09-01), None
Grigoriadis, Dimitri E., et al., “The CRF Receptor: Structure, Function and Potential for Therapeutic Intervention,”Curr. Med. Chem. —Central Nervous System Agents,2001, pp. 63-97, vol. 1, No. 1, Bentham Science Publishers Ltd.
Saito, et al., “Electrochemical formation of indazoles from tropone tosylhydrazones: electrochemical oxidations of sodium salts of tosylhydrazones of tropone and 2-phenyltropone,” Heterocycles, (1992) pp. 129-134, vol. 34:1.
Cournoyer Richard Leo
Loughhead David Garrett
O'Yang Counde
Buckwalter Brian L.
Roche Palo Alto LLC
Stockton Laura L.
LandOfFree
Indazole derivatives as CRF antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazole derivatives as CRF antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole derivatives as CRF antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3749883